Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Apr 5 2022

Full Issue

CDC Announces Plan To Modernize In Wake Of Pandemic Response

CDC Director Rochelle Walensky unveiled her agency's plan to revamp itself and hired an outside senior federal health official to conduct a one-month review.

The Washington Post: CDC, Under Fire For Covid Response, Announces Plans To Revamp Agency 

Centers for Disease Control and Prevention Director Rochelle Walensky announced plans Monday to revamp the agency that has come under blistering criticism for its performance leading the U.S. response to the coronavirus pandemic, saying, “it is time to step back and strategically position CDC to support the future of public health.” In an agencywide email sent shortly after 1 p.m., Walensky said she has hired a senior federal health official outside of the Atlanta-based agency to conduct a one-month review to “kick off an evaluation of CDC’s structure, systems, and processes.” (Sun, 4/4)

The New York Times: The C.D.C. Will Undergo A Comprehensive Re-Evaluation, The Agency’s Director Said

The move follows an unrelenting barrage of criticism regarding the agency’s handling of the pandemic over the past few months. The review will be conducted by Jim Macrae, who served as acting administrator of the Health Resources & Services Administration for two years and has held other senior positions at the federal Department of Health and Human Services, of which the C.D.C. is a part. Mr. Macrae will start his assignment on April 11.“The lessons from the Covid-19 pandemic, along with the feedback I have received inside and outside the agency over the past year, indicate that it is time to take a step back and strategically position CDC to support the future of public health,” Dr. Walensky said in an email to agency employees. (Rabin, 4/5)

Bloomberg: CDC Head Plans To Review Agency After Covid Response Criticism

The agency has repeatedly been criticized for Covid guidelines involving health workers, such as earlier this year when it shortened recommended periods for isolation and quarantine. After that, it came under fire for not backing routine testing for exposed people before resuming normal activities. Shortening those periods was intended to get exposed people back to work faster and help reduce staffing shortages. Still, some labor groups and public-health experts said the guidance prioritized the needs of businesses, supply chains and schools over those of vulnerable workers. (Rutherford, 4/4)

And in news from the National Institutes of Health —

Stat: NIH’s Cancer Chief, Ned Sharpless, To Step Down 

Ned Sharpless, the director of the National Cancer Institute, is stepping down at the end of April, he told STAT. Sharpless, 55, spent nearly five years leading the roughly $7 billion biomedical research agency, which is the largest of the 27 institutes that compose the National Institutes of Health. “I strongly support what this [administration] is doing to support cancer research, but it’s time for me to step aside,” he wrote in a text message. (Facher, 4/4)

AP: Holy Cross, Fauci's Alma Mater, To Name Building After Him

The College of the Holy Cross is naming its science center after Dr. Anthony Fauci, one of its most famous alumni, the school said Monday. “Dr. Fauci vividly personifies the distinctive characteristics of a Holy Cross education, and we know his life and work are already inspiring the next generation of empathetic servant leaders,” Vincent Rougeau, president of the Jesuit school in Worcester, Massachusetts, said in a statement. (4/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF